News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Stentys Expands Series B Round
June 26, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
pehub.com -- Stentys, a Paris, France-based maker of stents for use in acute myocardial infarction and blocked coronary-artery bifurcations, has raised $4.2 million in additional Series B funding from Crédit Agricole Private Equity.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
China
European biotech leaders split on US-China fight for deal dominance, survey finds
October 14, 2026
·
2 min read
·
Nick Paul Taylor
Insights
Beyond equity: Why venture debt is reshaping European biotech
October 8, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Insights
Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand
October 5, 2026
·
6 min read
·
Jennifer C. Smith-Parker
Insights
After COVID, biomanufacturing tackles preparedness and commercialization challenges
September 25, 2026
·
4 min read
·
Jennifer C. Smith-Parker
